Tuberculosis Meningitis
Conditions
Keywords
Tuberculosis meningitis
Brief summary
All patients who were alive at the end of the dexamethasone treatment trial conducted by Oxford University CLinical Research Unit from 2001-2005 (n=340) will be eligible to participate in this long-term follow-up study. All eligible and consenting patients will undergo an assesment consisting of a simple questionnaire, a clinical examination and a blood test. Data collected will focus on survival, neurological disability and tuberculosis relapse. Data will be collected in individual case record forms and entered into a computer database.
Interventions
Collection of mortality data at 5 years post trial
Sponsors
Study design
Eligibility
Inclusion criteria
Patients were alive at the end of the dexamethasone study (n=340) will be eligible to participate in this long-term follow-up study Informed consent
Exclusion criteria
Patients without informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Survival | 5 years |
Secondary
| Measure | Time frame |
|---|---|
| Neurological disability | 5 years |
| Tuberculosis relapse rate | 5 years |